Criscuolo C, Nepper G, Buchalter S Reflex sympathetic dystrophy following arterial blood gas sampling in the intensive care setting. Chest. 1995 Aug;108(2):578-80. Review.
Domino EF, Bartolini A, Kawamura H Effects of reticular stimulation, d-amphetamine and scopolamine on acetylcholine release from the hippocampus of brainstem transected cats. Arch Int Pharmacodyn Ther. 1977 Feb;225(2):294-302.
Klein WW, Brandt D, Kraft-Kinz J, Schreyer H [Dynamics and metabolism in coronary heart disease before and after revascularization intervention]. Acta Med Austriaca. 1976;3(3):69-73. German.
Middleton P, Kelly AM, Brown J, Robertson M Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J. 2006 Aug;23(8):622-4.
Mizock BA Controversies in lactic acidosis. Implications in critically ill patients. JAMA. 1987 Jul 24-31;258(4):497-501.
Mortensen JD Clinical sequelae from arterial needle puncture, cannulation, and incision. Circulation. 1967 Jun;35(6):1118-23.
Murdoch IA, Turner C, Dalton RN Arterial or mixed venous lactate measurement in critically ill children. Is there a difference? Acta Paediatr. 1994 Apr;83(4):412-3.
Weil MH, Michaels S, Rackow EC Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med. 1987 May;15(5):489-90.
Younger JG, Falk JL, Rothrock SG Relationship between arterial and peripheral venous lactate levels. Acad Emerg Med. 1996 Jul;3(7):730-4.
Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
